Uveitis Treatment Update: Humira May Be Alternative For Pati
People suffering from uveitis, a condition marked by chronic eye inflammation, may now have an alternative to commonly-used steroids in the form of the immune-suppressing drug Humira (adalimumab), according to a new study.

The U.S. Food and Drug Administration approved Humira, manufactured by AbbVie, for the treatment of uveitis in June this year. The new study, sponsored by the pharmaceutical company, was published Thursday in the New England Journal of Medicine.